Department of Surgery, Lahey Hospital & Medical Center, Burlington, MA, USA.
Department of General Surgery, Tufts Medical Center, Boston, MA, USA.
Ann Surg Oncol. 2023 Oct;30(10):6245-6253. doi: 10.1245/s10434-023-13904-7. Epub 2023 Jul 17.
The breast cancer surgical risk calculator (BCSRc) is a prognostic tool that determines a breast cancer patient's unique risk of acute complications following each possible surgical intervention. When used in the preoperative setting, it can help to stratify patients with an increased complication risk and enhance the patient-physician informed decision-making process. The objective of this study was to externally validate the four models used in the BCSRc on a large cohort of patients who underwent breast cancer surgery.
The BCSRc was developed by using a retrospective cohort from the National Surgical Quality Improvement Program database from 2005 to 2018. Four models were built by using logistic regression methods to predict the following composite outcomes: overall, infectious, hematologic, and internal organ complications. This study obtained a new cohort of patients from the National Surgical Quality Improvement Program by utilizing participant user files from 2019 to 2020. The area under the curve, brier score, and Hosmer-Lemeshow goodness of fit test measured model performance, accuracy, and calibration, respectively.
A total of 192,095 patients met inclusion criteria in the development of the BCSRc, and the validation cohort included 60,144 women. The area under the curve during external validation for each model was approximately 0.70. Accuracy, or Brier scores, were all between 0.04 and 0.003. Model calibration using the Hosmer-Lemeshow statistic found all p-values > 0.05. All of these model coefficients will be updated on the web-based BCSRc platform: www.breastcalc.org .
The BCSRc continues to show excellent external-validation measures. Collectively, this prognostic tool can enhance the decision-making process, help stratify patients with an increased complication risk, and improve expectant management.
乳腺癌手术风险计算器(BCSRc)是一种预后工具,可确定每位接受可能的手术干预的乳腺癌患者发生急性并发症的独特风险。在术前使用时,它可以帮助分层具有增加的并发症风险的患者,并增强患者-医生知情决策过程。本研究的目的是在接受乳腺癌手术的大量患者队列中对外科风险计算器的四个模型进行外部验证。
BCSRc 是使用 2005 年至 2018 年国家手术质量改进计划数据库中的回顾性队列开发的。使用逻辑回归方法构建了四个模型,以预测以下综合结局:总体、感染、血液和内部器官并发症。本研究通过利用 2019 年至 2020 年的参与者用户文件,从国家手术质量改进计划中获得了新的患者队列。曲线下面积、布里尔评分和 Hosmer-Lemeshow 拟合优度检验分别衡量模型性能、准确性和校准。
共有 192095 名患者符合 BCSRc 的纳入标准,验证队列包括 60144 名女性。在外部验证中,每个模型的曲线下面积均约为 0.70。准确性,或布里尔评分,均在 0.04 到 0.003 之间。使用 Hosmer-Lemeshow 统计量发现所有 p 值均>0.05,模型校准均通过。所有这些模型系数都将在基于网络的 BCSRc 平台上更新:www.breastcalc.org。
BCSRc 继续显示出出色的外部验证措施。总体而言,该预后工具可以增强决策过程,帮助分层具有增加的并发症风险的患者,并改善预期管理。